Physicians' responses to computerized drug-drug interaction alerts for outpatients

INTRODUCTION Adverse drug reactions (ADR) increase morbidity and mortality; potential drug-drug interactions (DDI) increase the probability of ADR. Studies have proven that computerized drug-interaction alert systems (DIAS) might reduce medication errors and potential adverse events. However, the relatively high override rates obscure the benefits of alert systems, which result in barriers for availability. It is important to understand the frequency at which physicians override DIAS and the reasons for overriding reminders. METHOD All the DDI records of outpatient prescriptions from a tertiary university hospital from 2005 and 2006 detections by the DIAS are included in the study. The DIAS is a JAVA language software that was integrated into the computerized physician order entry system. The alert window is displayed when DDIs occur during order entries, and physicians choose the appropriate action according to the DDI alerts. There are seven response choices are obligated in representing overriding and acceptance: (1) necessary order and override; (2) expected DDI and override; (3) expected DDI with modified dosage and override; (4) no DDI and override; (5) too busy to respond and override; (6) unaware of the DDI and accept; and (7) unexpected DDI and accept. The responses were collected for analysis. RESULTS A total of 11,084 DDI alerts of 1,243,464 outpatient prescriptions were present, 0.89% of all computerized prescriptions. The overall rate for accepting was 8.5%, but most of the alerts were overridden (91.5%). Physicians of family medicine and gynecology-obstetrics were more willing to accept the alerts with acceptance rates of 20.8% and 20.0% respectively (p<0.001). Information regarding the recognition of DDIs indicated that 82.0% of the DDIs were aware by physicians, 15.9% of DDIs were unaware by physicians, and 2.1% of alerts were ignored. The percentage of total alerts declined from 1.12% to 0.79% during 24 months' study period, and total overridden alerts also declined (from 1.04% to 0.73%). CONCLUSION We explored the physicians' behavior by analyzing responses to the DDI alerts. Although the override rate is still high, the reasons why physicians may override DDI alerts were well analyzed and most DDI were recognized by physicians. Nonetheless, the trend of total overrides is in decline, which indicates a learning curve effect from exposure to DIAS. By analyzing the computerized responses provided by physicians, efforts should be made to improve the efficiency of the DIAS, and pharmacists, as well as patient safety staffs, can catch physicians' appropriate reasons for overriding DDI alerts, improving patient safety.

[1]  H. Tey,et al.  Drug interactions in dermatological practice , 2008, Clinical and experimental dermatology.

[2]  Mei-Shu Lin,et al.  The Potential Drug-drug Interactions in an Ambulatory Prescription Data with Hypertensive Diagnosis in Taiwan(Hypertension, Clinical 8 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society) , 2005 .

[3]  M. Jann,et al.  Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients. , 2000, The Journal of clinical psychiatry.

[4]  J. Deligne,et al.  Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999 , 2003, European Journal of Clinical Pharmacology.

[5]  N. Laird,et al.  Incidence of adverse drug events and potential adverse drug events , 1995 .

[6]  K W Davidson,et al.  Reduction of adverse drug reactions by computerized drug interaction screening. , 1987, The Journal of family practice.

[7]  L. Kohn,et al.  To Err Is Human : Building a Safer Health System , 2007 .

[8]  P. Corey,et al.  Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .

[9]  D. Bates,et al.  Improving safety with information technology. , 2003, The New England journal of medicine.

[10]  A. Avery,et al.  GPs' views on computerized drug interaction alerts: questionnaire survey , 2002, Journal of clinical pharmacy and therapeutics.

[11]  David W Bates,et al.  CPOE and clinical decision support in hospitals: getting the benefits: comment on "Unintended effects of a computerized physician order entry nearly hard-stop alert to prevent a drug interaction". , 2010, Archives of internal medicine.

[12]  O. Olesen,et al.  Fluvoxamine-Clozapine drug interaction: inhibition in vitro of five cytochrome P450 isoforms involved in clozapine metabolism. , 2000, Journal of clinical psychopharmacology.

[13]  Roger B. Davis,et al.  Overrides of medication alerts in ambulatory care. , 2009, Archives of internal medicine.

[14]  J. Hernández,et al.  Adverse drug events in ambulatory care. , 2003, The New England journal of medicine.

[15]  Marc Berg,et al.  Overriding of drug safety alerts in computerized physician order entry. , 2006, Journal of the American Medical Informatics Association : JAMIA.

[16]  George Hripcsak,et al.  Detecting adverse events for patient safety research: a review of current methodologies , 2003, J. Biomed. Informatics.

[17]  Joan S. Ash,et al.  Research Paper: Emotional Aspects of Computer-based Provider Order Entry: A Qualitative Study , 2005, J. Am. Medical Informatics Assoc..

[18]  Barbara Simon,et al.  Exposure to Automated Drug Alerts Over Time: Effects On Clinicians’ Knowledge And Perceptions , 2006, Medical care.

[19]  D. Tatro Drug Interaction Facts , 1990 .

[20]  P Impicciatore,et al.  Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. , 2001, British journal of clinical pharmacology.

[21]  N. Laird,et al.  Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .

[22]  Julie M. Fiskio,et al.  Research Paper: Characteristics and Consequences of Drug Allergy Alert Overrides in a Computerized Physician Order Entry System , 2004, J. Am. Medical Informatics Assoc..

[23]  Sandra L Kane-Gill,et al.  A critical evaluation of clinical decision support for the detection of drug–drug interactions , 2011, Expert opinion on drug safety.

[24]  P. Glassman,et al.  Improving Recognition of Drug Interactions: Benefits and Barriers to Using Automated Drug Alerts , 2002, Medical care.

[25]  Yu-Chuan Li,et al.  The use of a CPOE log for the analysis of physicians' behavior when responding to drug-duplication reminders , 2008, Int. J. Medical Informatics.

[26]  Chien-Yeh Hsu,et al.  Potential drug interactions in dermatologic outpatient prescriptions—experience from nationwide population-based study in Taiwan , 2011 .

[27]  Donna C. Dare,et al.  Reasons provided by prescribers when overriding drug-drug interaction alerts. , 2007, The American journal of managed care.

[28]  R. Beurskens,et al.  Elevated plasma levels of clozapine after concomitant use of fluvoxamine , 1999, Pharmacy World and Science.

[29]  Roger B. Davis,et al.  Physicians' decisions to override computerized drug alerts in primary care. , 2003, Archives of internal medicine.